InvestorsHub Logo


Followers 1062
Posts 141582
Boards Moderated 14
Alias Born 03/31/2006


Re: Fress post# 96

Friday, 01/08/2021 6:53:24 AM

Friday, January 08, 2021 6:53:24 AM

Post# of 239
$EVGN I like this DD...

Assuming Lavie Bio (or its partners or agents) can obtain a 20% market share of the first focus market's 25 million acres, that works out to be $30 million (5 million acres at $6.00 per acre) for just the test market of "spring wheat". The cost of production of LAV211 is relatively low with an estimated gross margin in excess of 80%.

"Winter Wheat" is another potential market for LAV211. Winter wheat is planted in or about November, before the winter snow. After the snow melts, the winter wheat plants grow and are harvested in early spring. While the initial indication for LAV211 is "spring wheat," LAV211 may be expanded into the winter wheat at the same time in the future. According to Lavie Bio's CEO, the LAV211 market for winter wheat is potentially 5 to 10 times larger than spring wheat. The development testing and timing of LAV211 for "winter wheat" has not yet been released.

LAV211 can also likely be expanded into other agricultural crops such as oats, which is a lucrative market now because of the oatmilk market.

Potentially, LAV211 could generate annual revenues in the $100 million range for "spring wheat" and other products with commercial sales in the spring wheat market beginning in 2022. The market for LAV211 could be expanded further to other products but no further details have yet been provided. I note that Lavie Bio's Product Pipeline slide (shown earlier in this article) indicates a potential expansion to 500 million acres (compared to the 25 million acre "spring wheat" market.

Day Range:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EVGN News